Advertisement
U.S. markets open in 4 hours 2 minutes

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.0250-0.0050 (-0.25%)
At close: 04:00PM EST
2.1300 +0.10 (+5.19%)
After hours: 04:38PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close2.0300
Open2.4800
Bid0.0000 x 900
Ask0.0000 x 3000
Day's Range2.0000 - 2.0700
52 Week Range0.6800 - 5.4600
Volume146,831
Avg. Volume140,055
Market Cap56.269M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-2.0400
Earnings DateMar 07, 2024 - Mar 11, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for DRIO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • DarioHealth Corp.
    Analyst Report: Abbott LaboratoriesAbbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more